- Home
- IIIN vs EBS Comparison
IIIN vs EBS Comparison
Compare IIIN & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IIIN
- EBS
- Stock Information
- Founded
- IIIN 1953
- EBS 1998
- Country
- IIIN United States
- EBS United States
- Employees
- IIIN N/A
- EBS N/A
- Industry
- IIIN Steel/Iron Ore
- EBS Biotechnology: Pharmaceutical Preparations
- Sector
- IIIN Industrials
- EBS Health Care
- Exchange
- IIIN Nasdaq
- EBS Nasdaq
- Market Cap
- IIIN 515.0M
- EBS 518.0M
- IPO Year
- IIIN N/A
- EBS 2006
- Fundamental
- Price
- IIIN $27.00
- EBS $9.87
- Analyst Decision
- IIIN
- EBS Strong Buy
- Analyst Count
- IIIN 0
- EBS 3
- Target Price
- IIIN N/A
- EBS $14.33
- AVG Volume (30 Days)
- IIIN 179.1K
- EBS 1.1M
- Earning Date
- IIIN 01-16-2025
- EBS 03-04-2025
- Dividend Yield
- IIIN 0.44%
- EBS N/A
- EPS Growth
- IIIN N/A
- EBS N/A
- EPS
- IIIN 0.99
- EBS N/A
- Revenue
- IIIN $537,193,000.00
- EBS $1,125,500,000.00
- Revenue This Year
- IIIN $9.60
- EBS $6.26
- Revenue Next Year
- IIIN $16.98
- EBS $2.42
- P/E Ratio
- IIIN $27.34
- EBS N/A
- Revenue Growth
- IIIN N/A
- EBS 2.05
- 52 Week Low
- IIIN $23.60
- EBS $1.42
- 52 Week High
- IIIN $38.40
- EBS $15.10
- Technical
- Relative Strength Index (RSI)
- IIIN 50.86
- EBS 56.65
- Support Level
- IIIN $23.60
- EBS $9.20
- Resistance Level
- IIIN $26.79
- EBS $10.11
- Average True Range (ATR)
- IIIN 0.88
- EBS 0.67
- MACD
- IIIN 0.09
- EBS 0.04
- Stochastic Oscillator
- IIIN 75.56
- EBS 71.64
About IIIN Insteel Industries Inc.
Insteel Industries Inc manufactures steel wire reinforcing products for concrete construction applications. It manufactures and markets PC strand and welded wire reinforcement, including ESM, concrete pipe reinforcement, and standard welded wire reinforcement. The company's products are sold to manufacturers of concrete products that are used in nonresidential construction. Its concrete reinforcing products consist of two product lines: PC strand and WWR. Insteel generates its geographical revenue from the United States.
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. The company operates across three different segments, namely Commercial, Products, and Services. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.